Mirae Asset Capital Life Science - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2023
Mirae Asset Capital Life Science, based in New York City, focuses on providing financial solutions to companies in the life sciences sector. The firm typically invests in later-stage funding rounds, including Series C, supporting companies that are further along in their development and commercialization processes.
Notable portfolio companies include Accent Therapeutics, which has raised $75 million. Mirae Asset Capital Life Science is known for its strategic investments and support in the life sciences field, leveraging its expertise and network to help portfolio companies achieve significant milestones.
Mirae Asset Capital Life Science - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series C2 (66.7%)
Series B1 (33.3%)
Stage Mix
Series C 67%Series B 33%
Concentration shown as share of disclosed investments by stage.
